Navigation Links
Global Atrial Fibrillation Market is Expected to Reach USD 14.8 Billion in 2019: Transparency Market Research
Date:11/1/2013

Boehringer Ingelheim's Pradaxa, the market share of pharmacological treatment procedures is expected to further increase by 2019.

The non-pharmacological treatment market was led by the catheter ablation market and its market share was valued at over 45 percent in 2012. The introduction of new catheter ablation systems, such as CardioFocus's HeartLight Endoscopic Ablation System (EAS) laser ablation catheter, Endosense's TactiCath and Biosense Webster's ThermoCool SmartTouch, will help the catheter ablation market to further enhance its market share by 2019.

The radiofrequency based catheter ablation treatment for atrial fibrillation market led the catheter ablation market in terms of market share in 2012 majorly on account of the facts that it has a relatively lower procedural duration and cost and has high success rates associated with it.

High prevalence of atrial fibrillation, coupled with the availability of high disposable incomes amongst patients and sophisticated healthcare infrastructure, has led the North American atrial fibrillation market to hold the majority of the market share in 2012. However, this region is expected to lose its market share to relatively faster growing Asia-Pacific region.

Some of the key players of this market include Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Bayer/Johnson & Johnson, Medtronic, Inc., St. Jude Medical, Inc. and AtriCure, Inc.

Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart’s electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions. Being a potentially life threatening disease and expensive to treat, the overall healthcare system views the treatment for this condition as a strategically critical area to address. This report analyzes the market for atrial fibrillation market from the point of view of various pharmacologic
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Business Forecaster and Global Futurist Jack Uldrich to Keynote Indianapolis YPO Event
2. Global NAS Market 2012-2016 - New Report Available
3. Global Cardiac Bio Implant Devices (Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device)
4. Global Melanoma Therapeutics Market 2012-2016
5. Global Dental Implants Market 2012-2016
6. Global Green (Sustainable) Packaging Market 2012-2016
7. Facial Injectables Industry 2013 Global Analysis in New Report at MaretReportsOnline.com
8. BCC Research Publishes A New Report On Global Markets For Telemedicine Technologies
9. Global Survey Shows Personal Mobile Computing Devices Growing Into a Major Cyber Security Concern
10. Antibiotic Resistance 2013: A Global Market Study
11. Congenital Heart Disease Global Clinical Trials Review, H2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... York (PRWEB) September 21, 2014 ... their Risk Management Portal designed for Diocesan risks. ... the intent to support effective risk management and ... to go live coinciding with Waldorf’s exhibition at ... 2014. , These applications were developed in collaboration ...
(Date:9/21/2014)... Texas (PRWEB) September 22, 2014 ... the past decade, as it has become saturated ... beta-agonists (SABAs), inhaled corticosteroids (ICSs), inhaled corticosteroids and ... also been facing increasing generic competition. However, the ... once-daily ICS and ICS/LABA therapies delivered by the ...
(Date:9/21/2014)... "I want to help people who are having ... money for chiropractors," said an inventor from St. Amat, ... for myself." , The Stretch is a device that ... and align the spine properly. It improves flexibility and ... nerves. Compact and easy to use, it's ideal for ...
(Date:9/21/2014)... 2014 (HealthDay News) -- Young women starting college understand ... foods they should eat. But they aren,t confident they ... to a new study. The study involved ... Illinois,s Peer Education Exercising and Eating Right program. The ... choose to eat if they were very busy with ...
(Date:9/21/2014)... 2014 Originally approved by the ... Flovent (fluticasone propionate) is a synthetic ICS therapy ... the maintenance treatment of asthma prophylactically in children ... formulations, Diskus and HFA, which received the FDA ... ingredient, fluticasone propionate, can bind to glucocorticoid receptors ...
Breaking Medicine News(10 mins):Health News:Waldorf Risk Solutions Releases New Risk Management Portal 2Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4
... WellPoint, Inc. (NYSE: WLP ) announced ... New York Attorney General regarding the manner in which ... terms of the Agreement with the Attorney General, WellPoint ... database, which it uses in determining out-of-network reimbursement for ...
... RI Researchers at Rhode Island Hospital have completed ... control measures during a possible flu pandemic. Their study ... from individuals showing no symptoms (asymptomatic) or from individuals ... The researchers call on the scientific community to ...
... LOUISVILLE, Ky., Feb. 18 Almost Family, Inc. (Nasdaq: ... nursing services, announced today that it will be added to ... on Friday, February 20, 2009.William Yarmuth, President and CEO of ... included in the S&P SmallCap 600 Index, as it adds ...
... Taking Control of Your Diabetes,(TCOYD) announced findings ... firm Yankelovich that found that more than one ... that excess weight has a positive effect on,the ... often contributes,to the development of diabetes, complicates proper ...
... love their meat. Whether it,s rib eyes, pork chops or ... this country that more than 85 billion pounds of meat ... About a quarter of U.S. beef and pork is exported ... now the world,s largest consumer of meat, in Mexico, meat ...
... Spanish . , A team of specialists ... of genetic variants that have greater resistance to a specific ... some child patients affected by osteosarcoma. The team investigated the ... therapeutic treatment in the future. , In concrete, the research ...
Cached Medicine News:Health News:WellPoint Joins New York Attorney General in Creation of New Independent Database for Out-of-Network Reimbursement 2Health News:Study calls for increased research in flu transmission to prepare for pandemic flu outbreak 2Health News:Almost Family to be Added to the S&P SmallCap 600 Index 2Health News:One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease 2Health News:One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease 3Health News:American Veterinary Medical Association: Weaving a Web for Food Safety 2Health News:Research increases possibilities of personalizing treatment of infant osteosarcoma 2Health News:Research increases possibilities of personalizing treatment of infant osteosarcoma 3
(Date:9/19/2014)... , Sept. 19, 2014 "Copay ... inflate sales of brand drugs among patients with ... according to a new report  from the ... of the Inspector General (OIG). Federal anti-kickback laws prohibit ... that are subsidized by the federal government. ...
(Date:9/19/2014)... Today, iHealth Lab Inc. announced it has secured ... its first institutional round of funding. The strategic investment ... accelerate growth and innovation, and invest in additional sales ... Ventures will join iHealth,s board of directors, bringing added ... "We are very pleased to have Xiaomi ...
(Date:9/19/2014)... LUBBOCK, Texas , Sept. 19, 2014 Kiromic, ... today the addition of Kent Hance , the former ... vice chairman. Hance retired as chancellor in July 2014, after ... pleased to announce that Kent Hance , the most ... joined the Kiromic team not only as an investor, but ...
Breaking Medicine Technology:PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2
... Feb. 20, 2011 NxStage® Medical, Inc. ... innovative dialysis products, today announced the latest interim results ... in overall quality of life benefits, significant improvement in ... Legs Syndrome (RLS) symptoms experienced by patients after 12 ...
... One year to the day of its introduction, the ... to its official company launch.  "Starting a new company takes ... about the industry and our place in it and now ... healthcare." Dr. McCord is no stranger to healthcare. ...
Cached Medicine Technology:New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period 2New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period 3New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: